SEC Form 4 · accession 0001144204-15-037187
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Pierre Bizzari
Director
Period of report
Jun 11, 2015
Accepted (ET)
Jun 15, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.60 | Jun 11, 2015 | A | 14,000 | A | — | Jun 11, 2025 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1The options vests as follows: (i) 4,667 options vest on June 11, 2016; (ii) the remaining 9,333 shares vest in seven consecutive quarterly installments of 1,167 shares each on the 11th day of each respective month, beginning September 11, 2016 and continuing through March 11, 2018 with a final installment of 1,164 shares on June 11, 2018.